News: the new FDA cosmetics recalls landscape and other key updates
January 16, 2026
While the FDA strengthens cosmetic recalls, the EU and China are making important regulatory updates.
Updates, guidance and expert perspectives on regulatory affairs, compliance and market access across Brazil, the United States and Europe.
While the FDA strengthens cosmetic recalls, the EU and China are making important regulatory updates.
Entering the U.S. medical device market can be a major opportunity for international companies. However, to operate legally
Check out the main regulatory news of the week, including FDA ISO 13485 harmonization via QMSR, Anvisa, and
Learn how the Modernization of Cosmetics Regulation Act (MoCRA) transforms industry standards and how to achieve FDA compliance.
Discover a step-by-step guide to FDA medical devices approval, outlining the process, requirements, and key considerations for manufacturers.
Key changes for your biocompatibility strategy.
A practical guide to understand the 2025 update and what it means for your medical device documentation.
CLIENT VOICES
“
“Sobel provided a friendly, goal-oriented service with fast solutions. We look forward to working together on future projects.”
Andreas Kohl
CEO · Andratec
“
“I experienced always supportive, pro-active collaboration from Sobel Consult with high degree of competency in broad regulatory range.”
Mandy Blocher
Expert Regulatory Framework & Digital Transformation · Aesculap AG (B. Braun)
Clear regulatory direction
The right pathway and priorities for your product.
Fast and responsive support
We act quickly to keep projects moving.
Practical guidance
Actionable advice for your next step.
Subscribe to our newsletter to receive the latest updates and insights.
You may unsubscribe at any time using the link in our newsletter.
